These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34003997)

  • 1. Corneal Immune Cells Are Increased in Patients With Multiple Sclerosis.
    Khan A; Li Y; Ponirakis G; Akhtar N; Gad H; George P; Ibrahim FM; Petropoulos IN; Canibano BG; Deleu D; Shuaib A; Kamran S; Malik RA
    Transl Vis Sci Technol; 2021 Apr; 10(4):19. PubMed ID: 34003997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis.
    Bitirgen G; Akpinar Z; Malik RA; Ozkagnici A
    JAMA Ophthalmol; 2017 Jul; 135(7):777-782. PubMed ID: 28570722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study.
    Petropoulos IN; Al-Shibani F; Bitirgen G; Ponirakis G; Khan A; Gad H; Mahfoud ZR; Altarawneh H; Rehman MH; John K; Al-Merekhi D; George P; Uca AU; Ozkagnici A; Ibrahim F; Francis R; Canibano B; Deleu D; El-Sotouhy A; Vattoth S; Own A; Shuaib A; Akhtar N; Kamran S; Malik RA
    Ther Adv Neurol Disord; 2023; 16():17562864221118731. PubMed ID: 36776530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis.
    Petropoulos IN; Kamran S; Li Y; Khan A; Ponirakis G; Akhtar N; Deleu D; Shuaib A; Malik RA
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3677-3681. PubMed ID: 28727882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities.
    Chataway J; Murphy N; Khurana V; Schofield H; Findlay J; Adlard N
    Curr Med Res Opin; 2021 Jun; 37(6):995-1004. PubMed ID: 33733976
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive Loss of Corneal and Retinal Nerve Fibers in Patients With Multiple Sclerosis: A 2-Year Follow-up Study.
    Bitirgen G; Akpinar Z; Uca AU; Ozkagnici A; Petropoulos IN; Malik RA
    Transl Vis Sci Technol; 2020 Dec; 9(13):37. PubMed ID: 33384891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
    Choi IY; Lee P; Adany P; Hughes AJ; Belliston S; Denney DR; Lynch SG
    Mult Scler; 2018 Jul; 24(8):1029-1038. PubMed ID: 28569645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical dysfunction underlies disability in multiple sclerosis.
    Vucic S; Burke T; Lenton K; Ramanathan S; Gomes L; Yannikas C; Kiernan MC
    Mult Scler; 2012 Apr; 18(4):425-32. PubMed ID: 21965421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of definitions for conversion to secondary progressive MS in a Danish nationwide population.
    Kopp TI; Bramow S; Illes Z; Kant M; Kristensen C; Rasmussen PV; Sellebjerg F; Magyari M
    Mult Scler Relat Disord; 2021 Nov; 56():103319. PubMed ID: 34666241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis.
    Hjæresen S; Sejbaek T; Axelsson M; Mortensen SK; Vinsløv-Jensen H; Pihl-Jensen G; Novakova L; Pedersen CB; Halle B; Poulsen FR; Zhang M; Benedikz E; Frederiksen JL; Lycke J; Illes Z; Fex-Svenningsen Å
    J Neurol Sci; 2022 Aug; 439():120320. PubMed ID: 35717879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning.
    EkŞİ Z; ÇakiroĞlu M; Öz C; AralaŞmak A; Karadelİ HH; Özcan ME
    Arq Neuropsiquiatr; 2020 Dec; 78(12):789-796. PubMed ID: 33331515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.